HTG Molecular Diagnostics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $474.50 Thousand.
The company employs approximately 84 people and operates in the Technology sector, within the Scientific and Technical Instruments industry.
Over the past 12 months, HTG Molecular Diagnostics Inc. reported $6.21 million in revenue, generating net income of $-32.54 million.
Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker HTGM.